Brief: Sigilon Therapeutics Posts Q4 Loss Per Share of $0.55

Sigilon Therapeutics

14/03/2022 22:15

March 14 (Reuters) - Sigilon Therapeutics Inc  SGTX.O :
    * QTRLY LOSS PER SHARE $0.55
    * SAYS JOSIAS PONTES WAS EARLIER APPOINTED ACTING CFO 
    * Q4 EARNINGS PER SHARE VIEW $-0.56 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nGNX405rPX 
Further company coverage:  SGTX.O 

 ((Reuters.Briefs@thomsonreuters.com;))